A one health perspective on multidrug-resistant bacterial infections: integrated approaches for surveillance, policy and innovation
- PMID: 40969553
- PMCID: PMC12440884
- DOI: 10.3389/fcimb.2025.1614232
A one health perspective on multidrug-resistant bacterial infections: integrated approaches for surveillance, policy and innovation
Abstract
Multidrug-resistant (MDR) bacterial infections represent a growing global health emergency, driven by interconnected human, animal, and environmental factors. This review adopts a One Health perspective to explore the transmission dynamics, operational integration, and innovative responses to antimicrobial resistance (AMR). Case studies from China, India, Nigeria, Thailand, and Brazil underscore the effectiveness of regulatory reforms, surveillance networks, and public engagement campaigns. Notably, Artificial Intelligence (AI) is transforming MDR management through real-time diagnostics and resistance prediction, though ethical concerns and infrastructure deficits in Low- and Middle-Income Countries (LMICs) remain barriers. Community-led initiatives, gender-sensitive education, and policy reforms are vital to curbing misuse and closing equity gaps. Despite successes, challenges such as fragmented governance, underfunded labs, and limited longitudinal research persist. A proactive, integrated One Health approach-linking clinical, environmental, and policy actions-is essential for reducing MDR burden. Investment in intersectoral surveillance, equitable AI deployment, and community empowerment is imperative for safeguarding antibiotics and ensuring global health resilience.
Keywords: AI technologies; antimicrobial stewardship; environmental reservoirs; global health; inter-sectoral collaborations; multidrug-resistant (MDR) bacteria; one health; zoonotic MDR outbreaks.
Copyright © 2025 Ohia, Falodun, Adebudo and Bakarey.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Africa CDC (2023). Antimicrobial resistance surveillance in Africa: 2023 report (Addis Ababa: Africa CDC; ).
-
- Arcilla M. S., van Hattem J. M., Haverkate M. R., Bootsma M. C., van Genderen P. J., Goorhuis A., et al. (2017). Import and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae by international travellers (COMBAT study): a prospective, multicentre cohort study. Lancet Infect. Dis. 17, 78–85. doi: 10.1016/S1473-3099(16)30319-X, PMID: - DOI - PubMed
-
- Authority E. F. S., EMA E. M. A. (2021). Third joint inter-agency report on integrated analysis of consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from humans and food-producing animals in the EU/EEA: JIACRA III 2016-2018. EFSA J. 19, e06712. doi: 10.2903/j.efsa.2021.6712, PMID: - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
